Role of Magnesium Supplementation in Children with West Syndrome: A Randomized Controlled Clinical Trial
Yadav VK, Amrita A, Yadav S, Kumar R, Yadav KK
Iranian journal of child neurology · 3 citations
How it was studied
- Design
- Randomized controlled trial (classified by our AI screen)
- Studied in
- People
- Main outcome
- Health markers and function
Who paid for it
- Funding
- Independent funding
Based on full-text disclosure statement.
Publication
- Published
- 2022-01-01 · Iran J Child Neurol · vol. 16 · issue 1 · pp. 65–75
- Publisher
- National Institutes of Health
- Cited
- 4 citations · more than 54% of similar papers · 0.4× the field average
- References
- 22 works
- Access
- Open access (repository copy) · CC-BY
- Research areas
- Magnesium in Health and Disease · Epilepsy research and treatment · Neuroscience and Neuropharmacology Research
- Keywords
- Hypsarrhythmia, Medicine, Randomized controlled trial, Pediatrics, Epilepsy, Epileptic spasms, West Syndrome, Epilepsy syndromes, Clinical trial, Intervention (counseling), Encephalopathy, Internal medicine, Psychiatry
5 authors
From IN
- Vijay Kumar Yadav
- Amrita Amrita
- Sunita Kumari YadavAmbedkar University Delhi
- Rajeev KumarNarayana Health
- Krishna Kumar YadavDr. Ram Manohar Lohia Institute of Medical Sciences
Abstract
Objectives
West syndrome is a severe epileptic encephalopathy of young age. It is characterized by a clinico-electrical triad of infantile epileptic spasms, regression or arrest of psychomotor development, and hypsarrhythmia. In the last two decades, the large progress in the development of newer antiepileptic drugs has allowed us to have a vast choice of treatment options to control spasms, although they often fail to do so. Thus, there is a need to explore other treatment options.
Materials & methods
Subjects in this open-labelled randomized control trial were included newly diagnosed children of age between 3 months and 5 years of both genders. A total of 52 children were recruited and randomized into two groups: an intervention group (n=30) and a non-intervention group (n=22). Magnesium sulphate was provided for the intervention group but not for the non-intervention one. Both groups received the rest of the treatments, including adrenocorticotropic hormone and antiepileptic drugs. The follow-up period was three months, at the end of which a per-protocol analysis was performed.
Results
There was no significant difference in seizure control and neurodevelopmental outcome between both groups, but electroencephalogram significantly improved in the intervention group compared to the control. Also, the clinical response was better in patients with normal initial serum magnesium levels in the intervention group (p=0.003) than in other patients.
Conclusion
Magnesium supplementation may be helpful in children with West syndrome.
Abstract via Europe PMC. Copyright remains with the authors or publisher (CC BY).
Community trust
Loading…
How much do you trust this study's findings?
Comments
Sign in to rate, comment on or flag this study.Sign inSomething wrong here?
Flag this study if its information, labels or funding look wrong. An editor reviews every flag.
Sign in to rate, comment on or flag this study.Sign inEducational information about published research. Not medical advice, and not a recommendation to start or stop anything.